Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD4 (clone C0Z35L1G). We employs the pGEM (pBAD-Cy3-IL-4-EcoRI) vector components and the SynExpress system of the Exons Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD4
Clone
C0Z35L1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
pBAD
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.99
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.